OBJECTIVE: We sought to investigate the association of the EAT with CMR parameters of ventricular remodelling and left ventricular (LV) dysfunction in patients with non-ischemic dilated cardiomyopathy (DCM). DESIGN AND METHODS: One hundred and fifty subjects (112 consecutive patients with DCM and 48 healthy controls) underwent CMR examination. Function, volumes, dimensions, the LV remodelling index (LVRI), the presence of late gadolinium enhancement (LGE) and the amount of EAT were assessed. RESULTS: Compared to healthy controls, patients with DCM revealed a significantly reduced indexed EAT mass (31.7 ± 5.6 g/m(2) vs 24.0 ± 7.5 g/m(2) , p<0.0001). There was no difference in the EAT mass between DCM patients with moderate and severe LV dysfunction (23.5 ± 9.8 g/m(2) vs 24.2 ± 6.6 g/m(2) , P = 0.7). Linear regression analysis in DCM patients showed that with increasing LV end-diastolic mass index (LV-EDMI) (r = 0.417, P < 0.0001), increasing LV end-diastolic volume index (r = 0.251, P = 0.01) and increasing LV end-diastolic diameter (r = 0.220, P = 0.02), there was also a significantly increased amount of EAT mass. However, there was no correlation between the EAT and the LV ejection fraction (r = 0.0085, P = 0.37), right ventricular ejection fraction (r = 0.049, P = 0.6), LVRI (r = 0.116, P = 0.2) and the extent of LGE % (r = 0.189, P = 0.1). Among the healthy controls, the amount of EAT only correlated with increasing age (r = 0.461, P = 0.001), BMI (r = 0.426, P = 0.003) and LV-EDMI (r = 0.346, P = 0.02). CONCLUSION: In patients with DCM the amount of EAT is decreased compared to healthy controls irrespective of LV function impairment. However, an increase in LV mass and volumes is associated with a significantly increase in EAT in patients with DCM.
OBJECTIVE: We sought to investigate the association of the EAT with CMR parameters of ventricular remodelling and left ventricular (LV) dysfunction in patients with non-ischemic dilated cardiomyopathy (DCM). DESIGN AND METHODS: One hundred and fifty subjects (112 consecutive patients with DCM and 48 healthy controls) underwent CMR examination. Function, volumes, dimensions, the LV remodelling index (LVRI), the presence of late gadolinium enhancement (LGE) and the amount of EAT were assessed. RESULTS: Compared to healthy controls, patients with DCM revealed a significantly reduced indexed EAT mass (31.7 ± 5.6 g/m(2) vs 24.0 ± 7.5 g/m(2) , p<0.0001). There was no difference in the EAT mass between DCMpatients with moderate and severe LV dysfunction (23.5 ± 9.8 g/m(2) vs 24.2 ± 6.6 g/m(2) , P = 0.7). Linear regression analysis in DCMpatients showed that with increasing LV end-diastolic mass index (LV-EDMI) (r = 0.417, P < 0.0001), increasing LV end-diastolic volume index (r = 0.251, P = 0.01) and increasing LV end-diastolic diameter (r = 0.220, P = 0.02), there was also a significantly increased amount of EAT mass. However, there was no correlation between the EAT and the LV ejection fraction (r = 0.0085, P = 0.37), right ventricular ejection fraction (r = 0.049, P = 0.6), LVRI (r = 0.116, P = 0.2) and the extent of LGE % (r = 0.189, P = 0.1). Among the healthy controls, the amount of EAT only correlated with increasing age (r = 0.461, P = 0.001), BMI (r = 0.426, P = 0.003) and LV-EDMI (r = 0.346, P = 0.02). CONCLUSION: In patients with DCM the amount of EAT is decreased compared to healthy controls irrespective of LV function impairment. However, an increase in LV mass and volumes is associated with a significantly increase in EAT in patients with DCM.
Authors: Nisha Arenja; Johannes H Riffel; Manuel Halder; Charly N Djiokou; Thomas Fritz; Florian Andre; Fabian Aus dem Siepen; Thomas Zelniker; Benjamin Meder; Elham Kayvanpour; Grigorios Korosoglou; Hugo A Katus; Sebastian J Buss Journal: Eur Radiol Date: 2017-02-10 Impact factor: 5.315
Authors: Gijs van Woerden; Dirk J van Veldhuisen; Thomas M Gorter; Vanessa P M van Empel; Martin E W Hemels; Eric J Hazebroek; Sophie L van Veldhuisen; Tineke P Willems; Michiel Rienstra; Berend Daan Westenbrink Journal: Clin Cardiol Date: 2021-06-04 Impact factor: 2.882
Authors: Santiago Roura; Carolina Gálvez-Montón; David de Gonzalo-Calvo; Ana Gámez Valero; Paloma Gastelurrutia; Elena Revuelta-López; Cristina Prat-Vidal; Carolina Soler-Botija; Aida Llucià-Valldeperas; Isaac Perea-Gil; Oriol Iborra-Egea; Francesc E Borràs; Josep Lupón; Vicenta Llorente-Cortés; Antoni Bayes-Genis Journal: J Cell Mol Med Date: 2017-05-29 Impact factor: 5.310
Authors: Nitesh Nerlekar; Rahul G Muthalaly; Nathan Wong; Udit Thakur; Dennis T L Wong; Adam J Brown; Thomas H Marwick Journal: J Am Heart Assoc Date: 2018-12-04 Impact factor: 5.501
Authors: Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug Journal: Eur J Heart Fail Date: 2020-06-26 Impact factor: 15.534
Authors: F Hardt; M Becker; V Brandenburg; J Grebe; T Dirrichs; R F Gohmann; K Fehrenbacher; J Schmoee; S D Reinartz Journal: PLoS One Date: 2020-03-02 Impact factor: 3.240